Organization

Maria Skłodowska-Curie National Research Institute and Oncology Centre

1 abstract

Abstract

Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing biliary tract cancer (BTC) and pancreatic cancer (PC): Outcomes from DESTINY-PanTumor02 (DP-02).

Org: Maria Skłodowska-Curie National Research Institute and Oncology Centre, Hôtel-Dieu de Québec, Clinical Hospital “RZHD-Medicine”, Chi Mei Medical Center,